Browse News
Filter News
Found 47 articles
-
Biotechnology Market Size to Reach USD 5.68 Trillion by 2033
4/3/2024
According to the latest research by Nova One Advisor, the global biotechnology market size was valued at USD 1.54 Trillion in 2023 and is projected to reach USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% from 2024 to 2033
-
BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors
1/23/2024
BeiGene, Ltd., a global biotechnology company, announced that Olivier Brandicourt, M.D. has been appointed to its Board of Directors.
-
In the latest example of big pharma entering AI collaborations or using AI-based tools, AstraZeneca’s deal with Absci will aim to produce an oncology candidate.
-
Artificial Intelligence (AI) in Biopharmaceutical Market Size To Surpass USD 14.07 Bn By 2032
11/20/2023
The global artificial intelligence (AI) in biopharmaceutical market size was valued at USD 0.86 billion in 2022 and is projected to surpass around USD 14.07 billion by 2032, expanding at a remarkable CAGR of 32.3% from 2023 to 2032.
-
More and more companies are turning to artificial intelligence for drug safety prediction, but as with any new application of AI, experts urge caution.
-
Merck KGaA, Darmstadt, Germany, Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
9/20/2023
Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence -driven design and discovery capabilities, further advancing the company’s research efforts.
-
Exscientia Announces Expansion of its Technology Leadership Team
6/29/2023
Exscientia plc (Nasdaq: EXAI) announced today that it is expanding its technology management structure to accelerate application of Exscientia's innovative technologies to catalyse instrumental change in the way drug candidates are being discovered, designed and developed for patients in need of innovative therapies.
-
The AI drug discovery company’s reorganization will include laying off around 180 employees and dropping its atopic dermatitis candidate BEN-2293 in an effort to save nearly $56 million.
-
Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
2/1/2023
On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium, with four Charter Members: Bristol Myers Squibb, Janssen Research & Development, LLC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Novartis and Vesalius Therapeutics.
-
Pharnext Appoints Dr. Rob Quinn as Chief Financial Officer
9/1/2022
Pharnext SA, an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases with high unmet medical need, announces the appointment of Dr. Rob Quinn as Chief Financial Officer, effective immediately.
-
Artificial Intelligence in Drug Discovery Market is Expected To Reach USD 2.13 Billion By 2027 at a CAGR of 31.9%
8/29/2022
According to Reports and Data, the Artificial Intelligence in Drug Discovery Market was valued at USD 253.8 million in 2019 and is expected to reach USD 2,127.9 million by the year 2027, at a CAGR of 31.9%.
-
AI In Medical Imaging Market Size to Hit US$ 20.18 Billion by 2030
8/10/2022
According to Nova one advisor’s latest research report on the The global AI in Medical Imaging market gathered revenue around USD 20.18 billion by the end of 2030 and is estimated to expand at a modest CAGR of 36.9% during the prediction period 2022 to 2030.
-
Artificial Intelligence (AI) in MRI Market Size to Reach at USD 9.78 Billion by 2030
7/12/2022
According to Vision Research Reports, the global artificial intelligence in medical imaging market size was valued at USD 5.1 billion in 2021 and is expected to reach at USD 9.78 billion by 2030, poised to grow at a CAGR of 7.5% from 2022 to 2030.
-
Artificial Intelligence (AI) in Drug Discovery Market To Set Remarkable CAGR Growth of 41.0% By 2029 | Analysed By key Players, Future Trends, Industry Growth And Applications Overview
6/29/2022
A New Research on the Artificial Intelligence (AI) in Drug Discovery Market was conducted across a variety of industries in various regions to produce more than 350+ page reports.
-
The Global Cardiogenic Shock Market Is Expected To Reach US$ 6.32 Bn By 2032, Expanding At A CAGR Of 6.2% Over The 2022-2032 Period.
6/23/2022
Fact.MR – A Market Research and Competitive Intelligence Provider: The cardiogenic shock market is set to see strong expansion, expecting an incline of 6.2% CAGR across the 2022-2032 assessment period.
-
Artificial Intelligence in Medical Imaging Market Size, Report 2022-2030
6/23/2022
According to Vision Research Reports, the global artificial intelligence in medical imaging market is projected to grow at a CAGR of 36% during the forecast period 2022 to 2030 and to reach valuation of USD 20.1 billion by 2030.
-
AI in Medical Imaging Market Advanced Technology and New Innovations by 2031, Latest TMR Study
6/16/2022
Wilmington, Delaware, United States: Transparency Market Research delivers key insights on the global AI in medical imaging market.
-
Takeda announced results from its Phase III clinical trial on TAK-003, its dengue fever vaccine candidate, at the Northern European Conference of Travel Medicine.
-
Biopharma and life sciences organizations from across the globe provide updates on their businesses and pipelines.
-
AI in the Pharmaceutical Market Size to Worth Around USD 9.24 Bn by 2030
3/14/2022
The global AI in pharmaceutical market size is expected to be worth around USD 9.24 billion by 2030 from valued at USD 905.91 million in 2021 with a CAGR of 29.4% from 2021 to 2030.